Effect of nebivolol on nitric oxide availability and ADMA concentration in CAD patients after PCI: Prospective randomized double-blind study
Ali A.R. Aldallal, Maryam A. Razzaq, Ahmed M. Abdul Hameed, Huda Jabber Merza, Hasanain Kamil Hasan, Salam Jasim Mohammed · 2026
Read Effect of nebivolol on nitric oxide availability and ADMA concentration in CAD patients after PCI: Prospective randomized double-blind study by Ali A.R. Aldallal, Maryam A. Razzaq, Ahmed M. Abdul Hameed, Huda Jabber Merza, Hasanain Kamil Hasan, Salam Jasim Mohammed (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13551436.txt.
Description
A beta-blocker called nebivolol may do more than slow the heart: it may restore a gas the blood vessel lining needs. Aldallal and five co-authors tested that idea in a 2026 randomized trial. Their patients had coronary artery disease and had just received a stent to open a blocked vessel.
The trial enrolled 172 patients and split them, blinded, between nebivolol once a day and a placebo for 42 days. Blood tests at the start and end measured nitric oxide, the vessel-relaxing gas, and ADMA, a compound that blocks its production. Starting values matched across the groups. After treatment, the nebivolol group showed a marked rise in nitric oxide availability, the head of the report states, with the analysis adjusted for starting levels. The authors frame the drug as support for the vessel lining after stenting.
Catalog record
| CREATOR | Ali A.R. Aldallal, Maryam A. Razzaq, Ahmed M. Abdul Hameed, Huda Jabber Merza, Hasanain Kamil Hasan, Salam Jasim Mohammed |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |